Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
0.00%
)
US TECH 100
23,626.80
(
-0.71%
)
Dow Jones
46,225.15
(
0.00%
)
Brent Oil
109.17
(
2.43%
)
Bitcoin
69,688.72
(
-2.18%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DonShimoda post# 159723

Thursday, 04/11/2013 2:04:28 PM

Thursday, April 11, 2013 2:04:28 PM

Post# of 257257

XOMA—Considering the Eyegate Ph3 trial only matched SOC, I'm wondering if XOMA will eventual run a trial in anterior uveitis?

If Gevokicumab works in (non-anterior) NIU, it should also work in anterior disease; however, the unmet medical need is not as great in anterior disease, where generic steroids do an adequate job very cheaply.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now